Live Breaking News & Updates on Dean seal

Stay informed with the latest breaking news from Dean seal on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Dean seal and stay connected to the pulse of your community

MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit

By Dean Seal


MiMedx Group said federal regulators are sticking to their position that its Axiofill product doesn't meet regulatory requirements for a certain classification sought by the...

Georgia , United-states , Joseph-capper , Public-health-service , Mimedx-group , Drug-administration , Dean-seal , Medx-group , Executive-joseph-capper , Dow-jones , Markets ,

UPS Sets 2026 Revenue Target of $108 Billion to $114 Billion

By Dean Seal


United Parcel Service has set its financial targets for 2026 and said it is expecting about $108 billion to $114 billion in adjusted revenue that year.

The package-delivery...

Carol-tom , United-parcel-service , Dean-seal , Parcel-service , Executive-carol-tom , Dow-jones , Markets ,

Mesoblast Shares Jump After FDA Nod for Submission of Remestemcel-L Application

By Dean Seal


Mesoblast's American depositary receipts surged after the company got the go-ahead from regulators to submit a biologics license application for its remestemcel-L treatment for...

United-states , American , Drug-administration , Dean-seal , Dow-jones , Markets ,

Johnson & Johnson Gets FDA Fast-Track for Rare Pregnancy-Related Disease

By Dean Seal


Johnson & Johnson said the Food and Drug Administration has granted fast-track designation to its treatment for pregnant patients with fetal neonatal alloimmune...

Johnson , Drug-administration , Dean-seal , Dow-jones , Markets ,

Visa, Mastercard to Lower Fees in Landmark Settlement With Merchants

By Dean Seal


Visa and Mastercard have agreed to lower credit card interchange fees and cap rates into 2030 as part of a landmark settlement of long-running litigation with U.S. merchants.

...

Visa , Mastercard , Dean-seal , Dow-jones , Markets ,

SEC Fines Arista Co-Founder $1 Million Over Insider Trading Claims

By Dean Seal

The U.S. Securities and Exchange Commission said Andy Bechtolsheim, the co-founder of Sun Microsystems and Arista Networks, has agreed to pay almost $1 million to resolve claims...

Andy-bechtolsheim , Sun-microsystems , Arista-networks , Acacia-communications , Exchange-commission , Dean-seal , Wall-street , Dow-jones , Markets ,

DOJ Charges KuCoin, Founders with Anti-Money Laundering Violations

By Dean Seal


The Justice Department unsealed on Tuesday an indictment charging cryptocurrency exchange KuCoin and two of its founders with violating anti-money laundering laws.

Federal...

Commodity-futures-trading-commission , Justice-department , Bank-secrecy , Dean-seal , Chun-gan , Bank-secrecy-act , Dow-jones ,

DOJ Charges KuCoin, Founders With Anti-Money Laundering Violations -- Update

By Dean Seal


The Justice Department unsealed on Tuesday an indictment charging cryptocurrency exchange KuCoin and two of its founders with violating anti-money laundering laws.

Federal...

Johnny-lyu , Justice-department , Twitter , Bank-secrecy , Commodity-futures-trading-commission , Dean-seal , Chun-gan , Bank-secrecy-act , Executive-johnny-lyu , Dow-jones , Markets ,

Amneal Pharma Gets FDA Nod for Infection Fighting Drug Combination

By Dean Seal

Amneal Pharmaceuticals said the Food and Drug Administration has approved its abbreviated new drug application for ciprofloxacin and dexamethasone otic suspension, a combination...

Drug-administration , Amneal-pharmaceuticals , Dean-seal , Dow-jones ,

BeiGene Shares Rise on First Dosing of Brukinsa

By Dean Seal


American depositary receipts of BeiGene jumped after the company said the first doses of its lymphocytic leukemia treatment Brukinsa have been administered to patients in Armenia...

Nepal , Armenia , United-states , American , Max-foundation , Dean-seal , Dow-jones , Markets ,